← SynDRA

EVOBRUTINIB

SynDRA canonical compound SYN0039249 — structure-anchored drug synonym record

All known targets

• BTK

Mechanisms of action (all sources)

• BTK INHIBITOR
• Tyrosine-protein kinase BTK inhibitor
• Bruton's tyrosine kinase (BTK) inhibitor

Cross-references

• PubChem CID: 71479709
• ChEMBL: CHEMBL4072833
• DrugBank: DB15170
• KEGG: D12467
• PDB: MZJ
• Wikipedia: Evobrutinib
• TTD: D0QX8X

Synonyms

• Msc-2364447c
• Msc2364447c
• M-2951
• M2951
• UNII-ZA45457L1K
• ZA45457L1K
• 1-(4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidin-1-yl)prop-2-en-1-one
• 1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]piperidin-1-yl]prop-2-en-1-one
• Evobrutinib [INN]
• GTPL9752
• SCHEMBL14165673
• QUIWHXQETADMGN-UHFFFAOYSA-N
• MSC2364447C
• MSC-2364447C
• ZINC205623965
• AKOS032954004
• CS-6303
• MSC 2364447
• HY-101215
• A250 [WO2012170976]
• N-[(1-acryloylpiperidin-4-yl)methyl]-5-(4-phenoxyphenyl)pyrimidine-4,6-diamine
• 1-(4-((6-Amin
• evobrutinibum
• RefChem:139675
• US9580449, Example A39
• Evobrutinib?
• M-2951; Evobrutinib
• Evobrutinib (USAN/INN)
• EVOBRUTINIB [USAN]
• Evobrutinib (M-2951)
• EVOBRUTINIB [WHO-DD]
• BDBM291522
• BDBM291627
• EX-A2691
• US9580449, Example A250
• NSC800892
• s8777
• AB90800